Skip to main content
Premium Trial:

Request an Annual Quote

Bioinformatics Startup X-Mine Licenses Software to BioCardia

NEW YORK, Nov. 13 – Bioinformatics startup X-Mine said it has licensed its data-mining platform to BioCardia,  a developer of technologies and products designed to improve cardiac care

Under the terms of the deal, BioCardia, of South San Francisco, Calif., will also have early access to X-Mine’s future molecular pattern recognition and computational tools. 

“BioCardia is excited about this agreement with X-Mine, because we believe that X-Mine has a world class team of experts and a state of the art platform which can provide us with a substantial competitive advantage,” BioCardia CEO Peter Altman, said in a statement released Monday. 

X-Mine of Brisbane, Calif., markets X-Miner, a molecular pattern recognition software tool that provides users with insight into gene expression and proteomic data.

Financial terms of the deal were not disclosed.

 

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.